Understanding Your Lab Test: A Patient's Guide to Testing and Results
This test analyzes multiple genes in your blood or tissue sample to help diagnose and guide treatment for acute myeloid leukemia.
{"Identifies genetic mutations in AML to confirm diagnosis","Helps determine prognosis and risk stratification","Guides targeted therapy and treatment decisions","Performed on blood or tissue sample","Results help doctors personalize your treatment plan"}
Key facts at a glance
- LOINC
- 105343-8
- Short code
- AML-MGA
- Synonyms
- Acute myeloid leuk multi anl Bld/T
- Category
- chemistry
- Sample
- whole-blood
- Container
- EDTA tube (lavender/purple top) - 2 mL minimum, preferably 5 mL. For tissue samples, use sterile container with appropriate transport medium.
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- molgen
- CPT
- 81402
- SNOMED
- 92818004
- Specimen volume
- 2-5 mL whole blood in EDTA tube. For tissue specimens, minimum 1 cm³ of fresh tissue or formalin-fixed paraffin-embedded (FFPE) tissue block.
- Stability
- Whole blood: Room temperature acceptable for up to 24 hours; refrigerate at 2-8°C for up to 72 hours. Do not freeze whole blood. Tissue: FFPE blocks stable at room temperature; fresh tissue should be processed within 30 minutes or refrigerated.
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 168–336 hours
- Order
- routine
This test measures specific substances in a sample of your blood or other body fluid to help your doctor learn more about your health. Laboratory testing is a routine part of medical care and is used to check how well your body is working, to confirm or rule out a condition, and to guide decisions about your treatment.
Acute Myeloid Leukemia (AML) Multigene Analysis is a sophisticated molecular genetic test that examines multiple genes simultaneously from a blood or tissue sample. This test detects specific genetic mutations and abnormalities that are characteristic of AML, a type of cancer that affects the blood and bone marrow.
Your doctor may order this test if you have symptoms that need an explanation, as part of a routine checkup, to screen for a health problem before it causes symptoms, or to monitor a condition you already have. The results help your care team make informed decisions about your diagnosis and treatment plan.
Your doctor has ordered this test to help confirm a diagnosis of AML, determine the specific type of leukemia you have, assess how aggressive the disease may be, and identify specific genetic mutations that can be targeted with certain treatments. The results help your healthcare team develop the most effective treatment plan for your specific condition.
During the test, a trained health professional will take a small sample, usually from a vein in your arm. A tight band is placed around your upper arm, the skin is cleaned, and a thin needle is inserted to collect blood into a tube. The procedure typically takes only a few minutes, and the sample is then sent to a laboratory for analysis.
A healthcare professional will collect a blood sample from a vein in your arm, or in some cases, a small tissue sample may be taken from your bone marrow. The sample is then sent to a specialized laboratory where scientists use advanced molecular techniques to analyze the genetic material and identify specific mutations in multiple genes associated with AML.
Your results will show whether your values fall within a normal reference range or are higher or lower than expected. Your doctor will interpret the numbers along with your symptoms, medical history, and other test findings. Abnormal results do not always mean a serious problem, but they may lead to additional testing or a change in your treatment plan.
The test results will show which specific genetic mutations are present or absent in your sample. Different mutations can indicate different subtypes of AML, predict how the disease might behave, and help determine which targeted therapies may be most effective. Your doctor will interpret these results in the context of your overall health and other test findings.
This test is very safe, and serious problems are rare. You may feel a quick sting when the needle goes in, and slight bruising or soreness at the site for a day or two is common. Applying gentle pressure after the needle is removed helps reduce bruising. Contact your doctor if you have bleeding that will not stop or signs of infection.
The risks associated with this test are minimal and are mainly related to the blood or tissue collection procedure. These may include slight pain, bruising, or bleeding at the collection site, and in rare cases, infection. The laboratory analysis itself carries no direct risk to the patient.
Reference range
This is a qualitative molecular test. Reference range indicates absence of tested gene mutations. Results are reported as detected mutations, variants of uncertain significance (VUS), or wild-type (no mutations detected). Specific genes analyzed include but are not limited to: NPM1, FLT3, IDH1, IDH2, CEBPA, KIT, RAS, TP53, and other prognostic genetic markers relevant to Acute Myeloid Leukemia.N/A
No special preparation required. Collect specimen according to standard venipuncture protocol. Inform laboratory of suspected diagnosis or clinical indication. Provide relevant clinical history including prior treatments if applicable.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
AML multigene analysis plays a critical role in the diagnosis, classification, and management of acute myeloid leukemia. The specific genetic mutations identified help doctors determine the prognosis (likely outcome), stratify patients into risk groups, and select appropriate targeted therapies. Certain genetic mutations may respond better to specific drugs, making this test essential for personalized treatment planning. Additionally, this test can help monitor the disease during treatment and detect minimal residual disease, which is important for assessing treatment response.
Frequently asked questions
How long does it take to get results?
Do I need to fast before this test?
Will this test tell me if I have cancer?
Can this test predict if my leukemia will come back?
Does insurance cover this test?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy